Mark L. Ratner
In an IN VIVO article last spring, John Maraganore, PhD, president and CEO of Alnylam Pharmaceuticals Inc., wrote that pharma-biotech dealmaking was in some measure stalled because of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?